Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Autroadiographic characterization of sup 125 I-labeled 2,5-dimethoxy-4-iodophenylisopropylamine (DOI): A phenylisopropylamine derivative labeling both 5HT sub 2 and 5HT sub 1c receptors

Conference · · FASEB Journal (Federation of American Societies for Experimental Biology); (United States)
OSTI ID:5489268
; ; ; ; ;  [1]
  1. NIDA Addict. Res. Center, Baltimore, MD (United States) Dupont NEN, Boston, MA (United States) MCV/VCU, Richmond, VA (United States) Albany Medical College, NY (United States)

The best-characterized 5HT{sub 2} radioligands, such as ({sup 3}H)ketanserin and ({sup 3}H)spiperone, are antagonists that label both high- and low-affinity states of this receptor. Recently, the radiolabeled phenylisopropylamine hallucinogens DOB and DOI, which are agonists at 5HT{sub 2} receptors, have been demonstrated to label selectively the high-affinity state of brain 5HT{sub 2} receptors. In the present study, the authors determined optimum conditions for autoradiographic visualization of ({sup 125}I)DOI binding and characterized its pharmacology and guanine nucleotide sensitivity under those conditions. In slide-mounted tissue sections (rat forebrain; two 10 {mu}m sections/slide), ({plus minus})({sup 125}I)DOI binding was saturable, of high affinity (K{sub D}{approximately}4nM) and displayed a pharmacological profile (R({minus})DOI > spiperone > DOB > ({plus minus})DOI > ketanserin > S(+)DOI > 5HT > DOM) comparable to that seen in homogenate assays. Consistent with coupling of 5HT{sub 2} receptors to a guanine nucleotide regulatory protein, ({sup 125}I)DOI binding was inhibited by guanine nucleotides but not by ATP. In autoradiograms, high densities of ({sup 125}I)DOI binding sites were present in frontal cortex, olfactory tubercle, claustrum, caudate/putamen and mamillary nuclei with lower densities in trigeminal and solitary nuclei. The highest density of ({sup 125}l)DOI binding was observed in choroid plexus; these binding sites displayed a pharmacological profile characteristic of 5HT{sub 1C} receptors. These data suggest that ({sup 125}I)DOI labels both 5HT{sub 2} and 5HT{sub 1C} receptors.

OSTI ID:
5489268
Report Number(s):
CONF-9004153--
Journal Information:
FASEB Journal (Federation of American Societies for Experimental Biology); (United States), Journal Name: FASEB Journal (Federation of American Societies for Experimental Biology); (United States) Vol. 4:3; ISSN FAJOE; ISSN 0892-6638
Country of Publication:
United States
Language:
English